title: [Treatment of infantile parotid hemangioma with propranolol].
abstract: OBJECTIVE
  To evaluate the short-term results and safety of propranolol for the treatment of infantile parotid hemangioma.
  
  
  METHODS
  Oral propranolol was administered to 17 infants with parotid hemangioma at a dose of 1.0-1.5 mg per kilogram of body weight per day. The patients were revisited once a week. The changes of the tumor size, texture and colour were monitored and recorded at a regular interval. The adverse effects after medication were observed and managed accordingly. The short-term results were evaluated using a 4 scales system.
  
  
  RESULTS
  Among the 17 patients treated, the follow-up time was 5 to 10 months. The overall response was scale I in 0 patient, scale II in 0 patients, scale III in 5 patients, and scale IV in 12 patients. No serious adverse effects were encountered.
  
  
  CONCLUSIONS
  Oral propranolol at a lower dose is a safe and effective method for the treatment of infantile parotid hemangioma. The short-term results were excellent and the side effects minimal.
authors.affiliation: Department of Hemangioma, Tumor Hospital of Linyi City, Linyi Shandong 276000, China.
authors.forename: Xue-jian
authors.initials: XJ
authors.lastname: Liu
authors.forename: Zhong-ping
authors.initials: ZP
authors.lastname: Qin
authors.forename: Mao-zhong
authors.initials: MZ
authors.lastname: Tai
authors.forename: Ke-lei
authors.initials: KL
authors.lastname: Li
authors.forename: Chun-xiao
authors.initials: CX
authors.lastname: Ge
mesh_terms: D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D010307:Parotid Neoplasms / Q000188:drug therapy*; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol